Whitney & Co’s Biogen BIIB Stock Holding History

Whitney & Co’s Portfolio BIIB Stock Details BIIB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-149	Closed	-$49K	–	145
2018 Q3	$49K	Buy	149 +24	+19%	+$8.26K	0.01%	182
2018 Q2	$36K	Hold	125	–	–	0.01%	176
2018 Q1	$34K	Buy	+125	New	+$38.8K	0.01%	189

Other funds holding BIIB

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Whitney & Co's BIIB Position: Q4 2018 in Review

Whitney & Co sold out of Biogen (BIIB) in Q4 2018, closing a stake of 149 shares — an estimated $49K sold.

Whitney & Co first reported a position in BIIB in Q1 2018 and held it in 3 quarters. The position peaked at $49K in Q3 2018. 1,141 funds tracked by Wall St. Rank hold BIIB as of Q4 2018.

Whitney & Co reported no remaining Biogen position as of Q4 2018 after selling out during the quarter.
Whitney & Co sold 149 Biogen shares in Q4 2018, an estimated $49K.
Whitney & Co first reported a position in Biogen in Q1 2018 and held it in 3 quarters.
Whitney & Co's Biogen position peaked at $49K in Q3 2018.
1,141 funds tracked by Wall St. Rank held Biogen as of Q4 2018.

Based on Whitney & Co's 13F filing for Q4 2018, filed 7 Feb 2019.